Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01369030 · ClinicalTrials.gov registry record

Deplin® P.L.U.S. Program (Progress Through Learning Understanding & Support)

A clinical trial of Major Depressive Disorder, sponsored by Pamlab.

Completed
Registry status
554
Enrollment target
2
Study locations

NCT01369030 is a study of Major Depressive Disorder that has completed, run by Pamlab. The registered enrollment target is 554 participants, above the 375-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (48% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01369030, a study of Major Depressive Disorder, has completed, sponsored by Pamlab.

COMPLETED
Registry status
554 participants
Enrollment target
2
Study locations

Study Summary

This study will be an observational study in which patients who have been prescribed Deplin® are invited to participate in surveys regarding their experiences with Deplin®. The purpose of this study is to increase the understanding of the role of L-methylfolate among patients who are candidates for Deplin®, provide patients with personalized education and support, and contribute to the overall understanding of the needs and concerns of patients being treated for depression.

Conditions Studied

Interventions

  • OTHER Deplin®

Study Locations (2)

North Carolina

  • Moses Cone Family Practice Center - Greensboro

Tennessee

  • Vanderbilt University School of Medicine - Nashville

Trial Details

FieldValue
Enrollment Target 554 participants
Start Date 2010-11
Est. Completion 2012-04

Sponsor

Pamlab

8 total trials

What the Registry Record Tells You About NCT01369030

The ClinicalTrials.gov registry entry for NCT01369030 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 554 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 375-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (48% higher). The listed sponsor is Pamlab, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Deplin® is the first listed.

NCT01369030 reports 2 study locations spanning 2 distinct geographic areas - top geographies include North Carolina, Tennessee.

Frequently Asked Questions

What is clinical trial NCT01369030 about?

NCT01369030 is a clinical study titled "Deplin® P.L.U.S. Program (Progress Through Learning Understanding & Support)". This study will be an observational study in which patients who have been prescribed Deplin® are invited to participate in surveys regarding their experiences with Deplin®. The purpose of this study is to increase the understanding of the role of L-methylfolate among patients who are candidates for ...

What is the current status of trial NCT01369030?

This trial is currently completed. The enrollment target is 554 participants. The study started on 2010-11. Estimated completion is 2012-04.

What conditions does trial NCT01369030 study?

This clinical trial studies the following conditions: Major Depressive Disorder.

What interventions are being tested in trial NCT01369030?

The interventions under investigation include: Deplin® (OTHER).

Who is sponsoring clinical trial NCT01369030?

This trial is sponsored by Pamlab, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01369030 being conducted?

This trial has 2 study locations across North Carolina, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.